Trial explores drug-free approach to treat ADHD symptoms in children exposed to alcohol before birth

Noninvasive therapy aims to improve focus and behavior by gently stimulating a nerve linked to attention and executive function

2025-04-22

(Press-News.org) Researchers at UCLA Health are launching the first clinical trial to test whether a wearable device that delivers gentle nerve stimulation during sleep could ease ADHD symptoms in children with prenatal alcohol exposure.

Children exposed to alcohol in the womb have a heightened risk of developing ADHD-like symptoms including hyperactivity, impulsivity and executive function deficits such as difficulty paying attention, remembering, and organizing their behavior. Prenatal alcohol exposure affects about 5% of children in the U.S. with the majority developing these symptoms. These children are frequently less responsive to conventional pharmaceutical treatments for ADHD, such as psychostimulants, which can make the symptoms more disabling.

The two-year clinical trial, led by UCLA adjunct professor of child psychiatry Joseph O’Neill, will study whether a neurostimulation therapy may be an effective, at-home treatment option for these children.

Known as trigeminal nerve stimulation (TNS), the noninvasive therapy uses electrode patches attached to a small device that delivers gentle electric stimulation of the trigeminal nerve while the child sleeps. Parents place the electrode patches on the child’s forehead before bed, with the device left on overnight. This stimulation activates brain regions associated with attention and executive function.

The U.S. Food and Drug Administration cleared the first external TNS device in 2019 after studies showed it safely improved ADHD symptoms in children ages seven to 12. However, its effectiveness for treating ADHD symptoms specifically for children with prenatal alcohol exposure has not been studied.

“ADHD symptoms are highly disabling for children with prenatal alcohol exposure and difficult to manage for families. And these symptoms often fail to respond to standard treatment, such as drugs like methylphenidate, in children exposed to alcohol in the womb,” O’Neill said. “There is a pressing need for expanded therapeutic options for these children. So, we are looking forward to testing this very safe novel therapy that has been effective in unexposed children with ADHD.”

Funded by a $350,000 grant from the National Institutes of Alcohol Abuse and Alcoholism, the pilot clinical trial will involve 30 children ages eight to 12 with exposure to alcohol during gestation. Parents will be provided a Monarch eTNS device developed by the Los Angeles-based company NeuroSigma, Inc. to be used nightly for four weeks. The parents will keep track of the child’s executive function, sleep habits, negative side effects and any adverse events. Both parents and children will rate tolerability as well as their satisfaction with treatment.

If the treatment is determined to be feasible and effective, the study would proceed to a randomized crossover clinical trial. The NIAAA is set to provide up to $2.1 million for the three-year trial.

“I am thrilled to be a part of this innovative study that I hope will provide relief for both children and their families who suffer from the negative consequences associated with prenatal alcohol exposure because these children have so much to offer to society,” said study co-lead Mary O’Connor, professor emerita of psychiatry and biobehavioral sciences at the UCLA David Geffen School of Medicine.

The recruitment period for the trial is currently open. Interested families may contact the study by emailing ChildBrainStudy@mednet.ucla.edu, calling (310) 267-2710, or taking the online screener at https://bit.ly/TNS-PAE

END

ELSE PRESS RELEASES FROM THIS DATE:

New research points out a promising strategy for treating metastatic medulloblastoma

2025-04-22

Researchers at Baylor College of Medicine, Texas Children’s Hospital, the Hospital for Sick Children in Toronto and collaborating institutions reveal in Nature Cell Biology a strategy that helps medulloblastoma, the most prevalent malignant brain tumor in children, spread and grow on the leptomeninges, the membranes surrounding the brain and spinal cord. They discovered a novel line of communication between metastatic medulloblastoma and leptomeningeal fibroblasts that mediates recruitment and reprogramming of the latter to support tumor growth. The findings suggest that disrupting this communication offers a potential opportunity to treat this devastating ...

Light fields with extraordinary structure: plasmonic skyrmion bags

2025-04-22

“Our results add another chapter to the emerging field of skyrmion research,” proclaims Prof. Harald Giessen, head of the Fourth Physics Institute at the University of Stuttgart, whose group achieved this breakthrough. The team demonstrated the existence of “skyrmion bags” of light on the surface of a metal layer. A better understanding of physical phenomena Skyrmions are a mathematical description of vortex-like structures that help researchers better understand fundamental physical relationships. In recent years, this theoretical ...

DNA origami guides new possibilities in the fight against pancreatic cancer

2025-04-22

CHAMPAIGN, Ill. — One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. A new study uses DNA origami structures to selectively deliver fluorescent imaging agents to pancreatic cancer cells without affecting normal cells. The study, led by University of Illinois Urbana-Champaign mechanical science and engineering professor Bumsoo Han and professor Jong Hyun Choi at Purdue University, found that specially engineered DNA origami structures carrying imaging dye packets can specifically target human KRAS mutant ...

PREPSOIL launches assessment tool for soil living lab and lighthouse initiatives

2025-04-22

This tool is specifically designed to assess how well your initiative aligns with the EU Mission: A Soil Deal for Europe (Mission Soil) criteria for Soil Living Labs and Lighthouses, as further defined by the PREPSOIL taxonomy. Should your initiative meet the necessary criteria, you will be invited to participate in a more detailed assessment developed by the SOILL-Startup project. This next phase will provide an opportunity to join a network of 100 Soil Living Labs and ...

Lebanon crisis driving parents to seek unregulated “shadow” education, study shows

2025-04-22

Political and social crisis in Lebanon has forced parents to seek unregulated “shadow” education for their children, a new study shows. The government’s ongoing neglect of public education is intensifying social inequality, experts have warned. The current sectarian power-sharing arrangement has led to a diminished focus on schools, fostering privatization. The study shows how upheavals in Lebanon have exacerbated educational challenges for families across all socioeconomic groups, leading to an increasing reliance on the unregulated shadow education sector, particularly private ...

The AGA Research Foundation awards $2.4 million in digestive health research funding

2025-04-22

Bethesda, MD (April 22, 2025) — The American Gastroenterological Association (AGA) is proud to announce the selection of 74 recipients to receive $2.4 million in research funding through the annual AGA Research Foundation Awards Program. AGA also announces today the addition of 10 pilot grants, totaling $400,000 in funding, to the 2026 awards portfolio to ensure that scientific discovery continues despite federal funding cuts. “Since we established the AGA Research Foundation in 1984, AGA has been unwavering in the commitment to supporting ...

A repurposed anti-inflammatory drug may help treat alcohol use disorder and related pain

2025-04-22

LA JOLLA, CA—A preclinical study from scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity—two issues that commonly co-occur with alcohol use disorder (AUD). The results, published in JCI Insight on April 22, 2025, suggest that the drug apremilast—a phosphodiesterase-4 (PDE4) inhibitor, or a compound that blocks an enzyme involved in inflammation—could be repurposed as a dual-acting therapy for AUD, particularly in individuals who have pain during and after alcohol use. AUD ...

Obesity disrupts “reaction time” to starvation in mice

2025-04-22

Researchers led by Keigo Morita and Shinya Kuroda of the University of Tokyo have revealed a temporal disruption in the metabolism of obese mice when adapting to starvation despite no significant structural disruptions in the molecular network. This is a breakthrough discovery as research including the temporal dimension in biology has been notoriously laborious and extracting systematic insight from big data has been difficult. Thus, this study paves the way for further research into more general metabolic processes, such as food intake and disease progression. The findings were published in the journal Science Signaling. Living beings need to continuously extract energy from “food” ...

Listening to an avatar makes you more likely to gamble

2025-04-22

Expecting feedback from an avatar compared to a real human facilitates risk-taking behavior in a gambling task, and a brain region called the amygdala is central to this facilitation, according to a study published April 22nd in the open-access journal PLOS Biology by Toshiko Tanaka and Masahiko Haruno from the National Institute of Information and Communications Technology, Japan. In virtual-reality environments, individuals can adopt various forms of avatars, projecting their behaviors into a virtual realm where their interaction partners also appear as avatars. With this shift in ...

Facial expressions of avatars promote risky decision-making

2025-04-22

Highlights - Humans take more risks when interacting with facial expressions shown on avatars rather than real human faces. - This shift in risk-taking behavior is linked to activity in the amygdala. - The findings offer new insights into both the advantages and the cautionary aspects of communication via avatars. Abstract A research team led by Dr. TANAKA Toshiko and Dr. HARUNO Masahiko at the National Institute of Information and Communications Technology (NICT, President: TOKUDA Hideyuki Ph.D.), investigated how avatar-mediated communication affects human decision-making. They ...

Trial explores drug-free approach to treat ADHD symptoms in children exposed to alcohol before birth

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: